Christopher Krueger, Chief Business Officer at Ventyx Biosciences (NASDAQ:VTYX), reported a large exercise of company stock options on October 4, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Krueger, Chief Business Officer at Ventyx Biosciences, a company in the Health Care sector, just exercised stock options worth 15,000 shares of VTYX stock with an exercise price of $8.04.
Ventyx Biosciences shares are trading down 0.35% at $28.3 at the time of this writing on Thursday morning. Since the current price is $28.3, this makes Krueger's 15,000 shares worth $424,500.
Now trade stocks online commission free with Charles Schwab, ...